Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.890
+0.050 (1.76%)
May 8, 2025, 4:00 PM - Market closed

Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $225.51 million as of May 9, 2025. Its market cap has increased by 157.14% in one year.

Market Cap
225.51M
Enterprise Value
196.21M
1-Year Change
157.14%
Ranking
Category
Stock Price
$2.89

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $225.51M, an increase of 1,811.14%. That is a compound annual growth rate of 11.80%.

History

DateMarket Cap% Change
May 8, 2025225.50M62.93%
Dec 31, 2024138.40M6.54%
Dec 29, 2023129.90M87.18%
Dec 30, 202269.40M83.11%
Dec 31, 202137.90M-68.68%
Dec 31, 2020121.00M148.46%
Dec 31, 201948.70M5.64%
Dec 31, 201846.10M-50.11%
Dec 29, 201792.40M107.64%
Dec 30, 201644.50M-56.29%
Dec 31, 2015101.80M-40.95%
Dec 31, 2014172.40M-52.64%
Dec 31, 2013364.00M-24.96%
Dec 31, 2012485.10M14.93%
Dec 30, 2011422.10M-47.92%
Dec 31, 2010810.50M58.46%
Dec 31, 2009511.50M266.14%
Dec 31, 2008139.70M-45.71%
Dec 31, 2007257.30M2,552.58%
Dec 29, 20069.70M-21.77%
Dec 30, 200512.40M1,671.43%
Dec 31, 2004700.00K-41.67%
Dec 31, 20031.20M300.00%
Dec 31, 2002300.00K-57.14%
Dec 31, 2001700.00K-
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 674.60B
Johnson & Johnson 374.53B
UnitedHealth Group 349.75B
AbbVie 328.29B
Novo Nordisk 287.72B
Abbott Laboratories 233.14B
Novartis AG 215.89B
AstraZeneca 208.98B
Market Cap Rankings